Loading...
XSHE
000788
Market cap444mUSD
Jul 10, Last price  
5.23CNY
1D
3.36%
1Q
-17.51%
Jan 2017
-63.19%
Name

PKU HealthCare Corp Ltd

Chart & Performance

D1W1MN
XSHE:000788 chart
P/E
37.61
P/S
2.10
EPS
0.14
Div Yield, %
1.19%
Shrs. gr., 5y
—
Rev. gr., 5y
-7.90%
Revenues
1.48b
-28.04%
552,520,167879,448,4851,299,099,8731,955,689,2961,947,941,1882,316,469,2692,265,817,5352,010,726,3502,070,262,4562,145,918,0882,315,796,4292,509,080,0501,977,422,1462,236,776,3762,236,776,3752,077,355,1842,077,355,1842,193,796,7372,060,014,6421,482,371,745
Net income
83m
-39.94%
14,386,31565,334,195270,041,685115,198,06176,172,44078,020,489-27,104,33025,028,60112,559,07334,261,00945,178,55150,188,60239,181,48443,143,83843,143,84255,605,25055,605,25444,356,580137,992,60682,882,957
CFO
387m
+11.37%
24,750,11957,860,8830135,545,890110,610,08579,113,11096,188,34489,074,893165,991,410408,667,74800204,374,334-5,782,069-68,141,30959,142,996278,896,753121,843,415347,753,789387,291,557
Dividend
Oct 13, 20250.03 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Operating within China, PKU HealthCare Corp.,Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of medicinal products. Its extensive portfolio encompasses a broad spectrum of therapeutic areas, offering medications for conditions such as cancer (anti-tumor, oncology), neuropsychiatric disorders, cardiovascular issues, immune system regulation (immunosuppressive), infections (antimicrobial), pain and fever (antipyretic and analgesic), digestive ailments, allergies, blood sugar management, mental health, and blood volume expansion. Founded in 1965, the company was initially known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. before officially rebranding to PKU HealthCare Corp.,Ltd. in November 2013. Its primary operations are based out of its headquarters in Chongqing, China.
URL
http://www.pku-hc.com/
IPO date
Jun 16, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT